4/A: Bausch Health Companies Inc. Executive Awarded Restricted Share Units

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., received 39,126 restricted share units (RSUs) on February 29, 2024, according to a Form 4/A filing with the SEC.

Summary

• John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., was awarded 39,126 restricted share units (RSUs) on February 29, 2024.
• These RSUs will vest in three equal installments on the first three anniversaries of the grant date, contingent upon Barresi's continued service with the company.
• Vested RSUs will be settled in common shares of Bausch Health Companies Inc.
• This Form 4/A amends a previous filing (Form 4) from March 4, 2024, to correct an error in the vesting schedule description.

Sentiment

Score: 7

Explanation: The document describes a routine executive compensation event. It's a neutral to slightly positive event as it incentivizes management.

Positives

• The award of RSUs aligns the executive's interests with those of the shareholders, incentivizing continued service and performance.

Future Outlook

The vesting of the RSUs is contingent upon the reporting person's continued service, suggesting an expectation of continued employment.

Industry Context

Executive compensation packages often include stock-based awards like RSUs to align management's interests with shareholder value and incentivize long-term performance. This is a common practice in publicly traded companies.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns executive interests with company performance.
• The executive is incentivized to remain with the company and contribute to its success.

Key Dates